Statistics from Altmetric.com
Many interventions employed in the management of patients with acute coronary syndromes (ACS) have been proved to be beneficial through well-designed clinical trials. Practice guidelines describe these interventions and the level of evidence supporting their use.1 Notwithstanding concerns related to the “generalisability” of trial data to clinical practice, a consensus on what is “good practice” is achievable. Yet comparisons between hospitals have disclosed significant variations in the care provided,2 3 and in risk-adjusted outcome.4 5 The description and quantification of the various facets of care is predicated on the belief that the efficient performance of these tasks leads to better outcomes. So measurement of the performance of such interventions is an indication of “good care”, and these aspects of care become “performance indicators”.
EXISTING PERFORMANCE INDICATORS
Existing performance indicators for acute myocardial infarction in England and Wales were derived from the National Service Framework for Coronary Heart Disease (NSF for CHD)6 and have been collected through the Myocardial Infarction National Audit Project (MINAP). An annual report identifies each participating hospital and expresses its success or failure with respect to the official indicator (box 1) and the prescription of drugs for the prevention of subsequent cardiovascular events.
Box 1 Example of composite performance indicators: thrombolysis
For those with a final diagnosis of ST-elevation myocardial infarction a composite of 60 minute “call-to-needle time” and 30 minute “door-to-needle” time.
Band 1 <58% for call-to-needle and <75% for door-to-needle, without a 10% annual improvement in call-to-needle time (poor)
Band 2 <58% for call-to-needle and <75% for door-to-needle, with a 10% annual improvement in call-to-needle time
Band 3 ⩾58% for call-to-needle or ⩾75% for door-to-needle, without a 10% annual improvement in call-to-needle time
Band 4 ⩾58% for call-to-needle or ⩾75% for door-to-needle, with a 10% annual improvement in call-to-needle time
Band 5 ⩾58% for call-to-needle and ⩾75% for door-to-needle (good)
“Call-to-needle” is …
Competing interests: Dr Weston is associate director of the Myocardial Infarction National Audit Project, the central funding for which comes from the Healthcare Commission.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.